Seelos Therapeutics Inc (SEEL)

[eicoman]

OK, so there has been some delay, not unusual in bio-tech,
by year end Vitaros will be looking good, in EU, Switz, Middle East,
and I would be willing to bet Abbott launches Canada by Mid Summer


We expect to receive approval through the DCP in either the fourth quarter of 2012 or the first quarter of 2013 assuming no additional clock stops.

Switz - Accordingly, we currently expect a response by the end of 2012.

Middle east - Elis is responsible for the registration process in its territories. Based on the registration process, we currently expect approval in late 2012 or the beginning of 2013 in those territories.

Japan, Korea, China, India and Certain Other Asian Countries, bought back the rights